Management of Hematologic Disorders

  • Author: David Aboulafia, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/1/16 (What's New)

Summary

  • It is reasonable to assess HIV-infected patients for possible anemia treatment when hemoglobin reaches WHO threshold for defining anemia (< 13 g/dL in men or < 12 g/dL in women) (Management Guidelines)[WHO 2001]
  • Evidence that treating at this hemoglobin threshold will affect HIV clinical outcomes is equivocal
  • It is important not to overlook comorbidities that should be treated (Table 4)

Action required